By Stan Choe

Stocks ended mixed a day after falling to their worst loss since December, as Wall Street prepares for interest rates to stay higher for longer. The S&P 500 dipped 0.2% Wednesday after drifting between small gains and losses. The Dow fell and the Nasdaq rose. Treasury yields pulled back a bit after their surge the prior day. Yields have shot higher this month on expectations the Federal Reserve will be more aggressive on interest rates than markets had expected to drive down inflation. Minutes from the Fed’s last meeting showed policy makers still think inflation is too high despite a recent cooldown.

THIS IS A BREAKING NEWS UPDATE. AP’s earlier story follows below.

Stocks wavered between small gains and losses on Wall Street Wednesday, a day after falling to their worst loss since December on worries about higher interest rates.

The S&P 500 fell 0.2% after drifting between small gains and losses throughout the day. The Dow Jones Industrial Average fell 91 points, or 0.3%, at 33,037, as of 2:44 p.m. Eastern time, while the Nasdaq composite was up 0.1%.

After leaping at the start of the year, stocks hit a wall in February on worries that inflation may not be cooling as quickly or as smoothly as hoped. That has Wall Street upping its forecasts for how high the Federal Reserve will take interest rates, as well as for how long it will keep them at that level.

High rates can help drive down inflation, but they raise the risk of a recession because they slow the economy. They also hurt investment prices.

Yields in the Treasury market have shot higher this month after several stronger-than-expected reports on the economy forced the recalibration by Wall Street, which had earlier built bets that easing inflation would get the Fed to take it easier on interest rates soon.

The yield on the 10-year Treasury is near its highest level since November. It pulled back a bit from its surge on Tuesday, dipping to 3.91% from 3.95%. That helped take some pressure off stocks on Wednesday.

The two-year yield, which moves more on expectations for the Fed, fell to 4.68% from 4.73%. It’s also been near its highest level since November. If it tops that level, it would be at its highest since 2007.

Traders have in recent weeks reduced bets that the Fed could cut rates later this year. Now they’re in closer alignment with what Fed officials have been telling the market for months, if not preparing for even more.

Investors are penciling in at least two more rate hikes of 0.25 percentage points. They’re even talking about the possibility that the Fed may consider going back to increases of 0.50 points.

The Fed has brought its main overnight rate up to a range of 4.50% to 4.75%, up from virtually zero at the start of last year, in its drive to stamp out high inflation. It’s also said it envisions no cuts to rates this year.

Minutes from the central bank's last policy meeting showed that nearly all of its policymakers agreed earlier this month to slow the pace of their rate increases to a quarter-point. Its next move on rates will be next month.

Traders see a nearly three-in-four chance that the Fed will raise rates by 0.25 points, according to CME Group. They see a 24% chance of a hike of 0.50 points. A month ago, traders were seeing a roughly 21% chance that the Fed wouldn't raise rates at all in March.

A relatively lackluster earnings reporting season for big U.S. companies is winding down, and some of Wednesday's biggest losers dropped despite reporting better results for the latest quarter than expected. That's because investors have been putting more emphasis on what companies say about their upcoming results, with worries high about rising costs and high inflation eating into profits.

Charles River Laboratories dropped 11.9% despite topping forecasts for the latest quarter. It said it received a U.S. Justice Department subpoena related to shipments of non-human primates that the company received from its supplier in Cambodia. The company said it voluntarily suspended such shipments, which pushed it to cut its forecast for revenue this upcoming year.

Keysight Technologies tumbled 13.5% for the largest loss in the S&P 500 despite also reporting stronger profit and revenue for the latest quarter than expected. Analysts pointed to its reporting of softer orders than forecast.

On the winning side was Diamondback Energy, which rose 2.1% after it reported a stronger profit for its latest quarter than analysts expected.

___

AP Business Writers Damian J. Troise, Yuri Kageyama and Matt Ott contributed.

Share:
More In Business
Evaluating Blue Origin's Potential After Third Successful Manned Launch
Blue Origin launched its third manned mission over the weekend with 'Good Morning America' host Michael Strahan and Laura Shepard Churchley, daughter of astronaut Alan Shepard on board, alongside several Blue Origin investors. This comes after the spaceflight firm launched two successful missions to the edge of space earlier this year. How will these missions set up Blue Origin for success as it competes with SpaceX and other companies for space tourism domination and more? Joey Roulette, space reporter at The New York Times, joins Cheddar News' Closing Bell to discuss.
Inflation Surges Faster Than Expected to 6.8% in November
If there's any question about whether inflation is here to stay, today's November consumer price index data gives us an answer. This is the second month in a row we've seen a hot inflation reading — CPI last month rose to 6.8%, after jumping to 6.2% in October. Amid the holiday shopping season, what does this mean for consumers? And how will the Federal Reserve move forward after previously announcing it would speed up its asset taper timeline? Art Hogan, Chief Market Strategist at National Securities, joins Cheddar News' Closing Bell to discuss November's CPI jump, where consumers are hurting the most, what the Fed could do to help ease inflation, and more.
Getty Images CEO on Now Being the Right Time to Go Public
Editorial and stock photo provider Getty Images is gearing up to make its public debut via a SPAC merger with CC Neuberger Principal Holdings II bringing it to a $4.8 billion valuation. CEO Craig Peters joined Cheddar to break down the decision to go public and noted that the merger will help to pay down debt. "That's going to really enable a lot of additional free cash flow and financial flexibility into the business," he noted. "That's just going to allow us to just invest more aggressively into the business to accelerate what is already accelerating growth." Peters also discussed the legacy image platform's place going forward in the expanding world of digital assets like NFTs and the metaverse.
Coindesk Unveils List of the Most Influential People in Crypto for 2021
Ben Schiller, the managing editor for features and opinion at CoinDesk, breaks down how the year's top 10 crypto influencers were selected and what to expect from the blockchain ecosystem, especially the growth of NFTs, in 2022. "This whole crypto story has become not just a story about money or the future of money," he said. "It's also become a cultural story where it's getting into gaming, it's getting into artwork, into collectibles, and all kinds of cultural categories it wasn't in before." Schiller noted that he expects the U.S. and other world governments to establish crypto regulations in the coming year.
Astrazeneca COVID Antibody Treatment for the Immunocompromised Gets FDA Approval
Mina Makar, senior vice president of respiratory and immunology, Astrazeneca, joined Cheddar to discuss the FDA's decision to give emergency use authorization to the pharma giant's COVID-19 antibody treatment called Evusheld for immunocompromised patients For about 2 percent of the U.S. Makar noted that the injection is supposed to provide antibody protection for those who can't generate their own adequate immune response via the vaccines for a minimum of six months, though long-term trials are underway.
Salesforce Chief Medical Officer on Growing Need for C-Suite Healthcare Role
The pandemic has forced corporate America to reshape itself to adapt, including onboarding doctors as chief medical officers to help maintain the health and safety of staff. Dr. Geeta Nayyar, chief medical officer at Salesforce, joined Cheddar to break down her role and how it has become relevant and necessary in the evolving workplace. "Every business today is now in the business of healthcare," she said. "It is a priority to empower employees to then serve your customers."
Eco-Friendly Biz Grove Collaborative CEO on Going Public Via Branson-Backed SPAC
Sustainable consumer products maker Grove Collaborative is gearing up to launch an IPO via a SPAC merger with Richard Branson's Virgin Group Acquisition Corp II. Stuart Landesberg, CEO and co-founder of Grove Collaborative, talked to Cheddar's Kristen Scholer about going public through the merger and aligning with a partner he felt also prioritizes climate. "What this partnership will mean is that we're able to expand the assortment and innovations that we bring to market in products that work just as well as the conventionals and market leaders but have a significantly different environmental profile," Landesberg said.
Visa Looks to Make Cryptocurrency a Mainstream Asset
Cuy Sheffield, head of crypto at Visa, joined Cheddar's "Closing Bell" to talk about Visa's commitment and the partnerships the company has established to make crypto a conventional form of currency. He noted that banks are becoming more receptive to digital currency as their customers move portions of money to crypto platforms and also explained steps Visa is taking to make them more climate conscious.
Load More